Medical Science Liaison - East Coast

Remote

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Stem Cell TherapyIndustries

Requirements

Candidates must possess an advanced degree such as M.D., D.O., PharmD, or PhD in a medically related field, or a Master's degree in health sciences with relevant medical affairs experience. A minimum of 3 years of experience as a Medical Science Liaison or in a related Medical Affairs or Clinical Development role is required, along with at least 1 year of experience in rheumatology and/or cell therapy. The ideal candidate will have experience in a field-based role, strong personal integrity, excellent communication and presentation skills, and reside within the territory. A working knowledge of US legal, regulatory, and compliance regulations is also necessary.

Responsibilities

The Medical Science Liaison will identify and engage with key opinion leaders in Rheumatology, support advisory boards and research, and assess collaboration opportunities. They will establish and maintain relationships with healthcare professionals and clinical sites, and develop territory plans. Responsibilities include delivering approved medical and scientific education about disease states and the company's technology, sharing insights to inform medical strategies, and representing the company at scientific conferences. The role also involves enhancing clinical trial awareness, supporting site recruitment and training, and collaborating cross-functionally with internal teams. Staying current with clinical data and scientific publications is essential.

Skills

Rheumatology

Clinical Studies

Field-based role

Key Opinion Leader (KOL) engagement

Healthcare professional relationship building

Clinical site engagement

Patient community engagement

Advisory boards

Investigator-initiated research

Scientific collaboration

Territory planning

Medical education

Cell therapy

Clinical trials

Scientific conferences

Medical congresses

Clinical Operations

Regulatory affairs

Pharmacovigilance

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free